PubRank
Search
About
Karl J Dykema
Author PubWeight™ 27.24
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes.
Nature
2010
14.50
2
Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
Am J Surg Pathol
2008
1.70
3
Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
Carcinogenesis
2005
1.59
4
Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response.
Sci Signal
2011
1.58
5
Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response.
PLoS Genet
2008
1.20
6
Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models.
Cancer Res
2009
1.15
7
Comparison of array-based comparative genomic hybridization with gene expression-based regional expression biases to identify genetic abnormalities in hepatocellular carcinoma.
BMC Genomics
2005
1.14
8
Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.
BMC Med Genomics
2010
1.06
9
Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas.
Proc Natl Acad Sci U S A
2011
1.05
10
MK-STYX, a catalytically inactive phosphatase regulating mitochondrially dependent apoptosis.
Mol Cell Biol
2011
0.86
11
MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cells.
PLoS One
2011
0.84
12
Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma.
Mol Cancer Ther
2013
0.83
13
Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.
PLoS One
2012
0.79